Shilpa Medicare Unit VI Bengaluru facility receives Saudi Arabian GMP certification

Published On 2025-07-10 07:19 GMT   |   Update On 2025-07-10 07:19 GMT
Advertisement

Karnataka: Shilpa Medicare has announced that its Unit VI facility, located at Dabaspet, Bengaluru, Karnataka, has received SFDA, Saudi Arabia, GMP certification.

This follows the on-site inspection of this Site from 18 – 20th Feb 2025.

This was a full GMP inspection of entire facility with specific focus on Ondansetron Oral Film drug product.

The inspection was closed with ZERO observations.

This facility of Shilpa Medicare Ltd is engaged in the manufacture, testing, storage and release of finished dosage forms in the category of Oral Films and Transdermal Patches. Oral Films are currently being supplied from this Site to US, Australia and other Emerging countries. The Site is approved by European Medicine Agency, Europe following a recent inspection by Finnish regulators.

Read also: Shilpa Medicare arm partners with Orion Corporation for Recombinant Human Albumin for European Market

Shilpa Medicare is a global pharmaceutical company specializing in contract development and manufacturing services for small and large molecules. With a strong emphasis on oncology and a growing presence in biologics, the company offers comprehensive solutions from discovery to commercial supply. Shilpa Medicare operates R&D and manufacturing facilities, serving partners across North America, Europe, and Asia.

Read also: Shilpa Pharma Lifesciences Unit-1 successfully completes GMP inspection from Brazilian regulatory authority

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News